Latest Market Access News

Pilot Energy has initiated a formal farmout process to attract partners for its offshore Perth Basin permit WA-481P, featuring the ready-to-drill Leander Gas Prospect with 1.1 trillion cubic feet of prospective gas resources.

Microba Life Sciences reports record Q4 FY25 microbiome test sales in Australia and the UK, underpinned by landmark clinical studies and a $14.5 million capital raise. The company is transitioning away from legacy products to focus on high-value diagnostics, positioning for sustained growth in FY26.

Macro Metals Limited and WA Limestone have completed the acquisition of the Derby East Construction Sands Project near Derby, WA, positioning themselves to tap into growing Southeast Asian sand markets. The project offers low-risk mining potential with strong logistics links to the Port of Derby.

Linius Technologies has landed a paid Proof of Concept with a leading European soccer league, aiming to showcase its video search and assembly platform to boost fan engagement. This deal could open doors to significant Tier 1 contracts in the lucrative European football market.

Lumos Diagnostics has locked in a A$5 million secured loan facility to support working capital as it advances toward FDA CLIA waiver for its FebriDx® test, complementing a landmark US distribution deal.

BPH Global Ltd reports a 17.7% revenue increase to A$177,316 in its second month of seaweed sales from Indonesia, signaling early commercial traction and sustainable growth potential.

Lumos Diagnostics has inked a landmark six-year exclusive distribution agreement with PHASE Scientific for its FebriDx® rapid diagnostic test in the US, potentially unlocking nearly half a billion Australian dollars in revenue contingent on FDA approval.

Li-S Energy has appointed Paladin Defense Services as its U.S. representative to accelerate engagement with the Department of Defense and defence contractors, aiming to commercialise its advanced battery technology in a critical market.

Tissue Repair Limited has secured major distribution partnerships in Australia, New Zealand, and Thailand for its TR Pro+® product line, marking a pivotal shift from development to commercialisation. The company is also scaling up manufacturing and advancing regulatory approvals to support its global expansion ambitions.

Almonty Industries has had its trading suspension lifted following the release of an updated technical report on its Sangdong Project in South Korea, signaling renewed investor access and potential project reassessment.

Telix Pharmaceuticals has achieved a key milestone with its next-generation prostate cancer imaging agent, Gozellix, receiving a permanent HCPCS code from U.S. Medicare. This paves the way for broader reimbursement and market adoption starting October 2025.

MTM Critical Metals has appointed Gregory L. Bowman, a seasoned U.S. defense and industrial strategy expert, to the advisory board of its U.S. subsidiary Flash Metals USA, aiming to accelerate its critical metals refining technology and deepen ties with U.S. government stakeholders.